Extendicare Stock Performance
| EXETF Stock | USD 16.98 0.35 2.02% |
On a scale of 0 to 100, Extendicare holds a performance score of 23. The firm shows a Beta (market volatility) of 0.33, which means possible diversification benefits within a given portfolio. As returns on the market increase, Extendicare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Extendicare is expected to be smaller as well. Please check Extendicare's maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to make a quick decision on whether Extendicare's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Extendicare are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Extendicare reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 180 M | |
| Total Cashflows From Investing Activities | -63.7 M |
Extendicare |
Extendicare Relative Risk vs. Return Landscape
If you would invest 1,151 in Extendicare on November 1, 2025 and sell it today you would earn a total of 547.00 from holding Extendicare or generate 47.52% return on investment over 90 days. Extendicare is currently producing 0.6637% returns and takes up 2.265% volatility of returns over 90 trading days. Put another way, 20% of traded pink sheets are less volatile than Extendicare, and 87% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Extendicare Target Price Odds to finish over Current Price
The tendency of Extendicare Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 16.98 | 90 days | 16.98 | about 12.62 |
Based on a normal probability distribution, the odds of Extendicare to move above the current price in 90 days from now is about 12.62 (This Extendicare probability density function shows the probability of Extendicare Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Extendicare has a beta of 0.33 suggesting as returns on the market go up, Extendicare average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Extendicare will be expected to be much smaller as well. Additionally Extendicare has an alpha of 0.6368, implying that it can generate a 0.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Extendicare Price Density |
| Price |
Predictive Modules for Extendicare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Extendicare. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Extendicare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Extendicare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Extendicare is not an exception. The market had few large corrections towards the Extendicare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Extendicare, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Extendicare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | 0.33 | |
σ | Overall volatility | 1.59 | |
Ir | Information ratio | 0.27 |
Extendicare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Extendicare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Extendicare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| About 13.0% of the company shares are held by company insiders |
Extendicare Fundamentals Growth
Extendicare Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Extendicare, and Extendicare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Extendicare Pink Sheet performance.
| Return On Equity | 0.0018 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 556.43 M | |||
| Shares Outstanding | 83.94 M | |||
| Price To Earning | 500.00 X | |||
| Price To Book | 4.28 X | |||
| Price To Sales | 0.32 X | |||
| Revenue | 1.22 B | |||
| EBITDA | 79.64 M | |||
| Cash And Equivalents | 174.61 M | |||
| Cash Per Share | 2.08 X | |||
| Total Debt | 463.27 M | |||
| Debt To Equity | 2.85 % | |||
| Book Value Per Share | 1.49 X | |||
| Cash Flow From Operations | 63.42 M | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 900.32 M | |||
About Extendicare Performance
By analyzing Extendicare's fundamental ratios, stakeholders can gain valuable insights into Extendicare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Extendicare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Extendicare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. Extendicare Inc. was founded in 1968 and is based in Markham, Canada. Extendicare operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.Things to note about Extendicare performance evaluation
Checking the ongoing alerts about Extendicare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Extendicare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 13.0% of the company shares are held by company insiders |
- Analyzing Extendicare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Extendicare's stock is overvalued or undervalued compared to its peers.
- Examining Extendicare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Extendicare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Extendicare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Extendicare's pink sheet. These opinions can provide insight into Extendicare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Extendicare Pink Sheet analysis
When running Extendicare's price analysis, check to measure Extendicare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Extendicare is operating at the current time. Most of Extendicare's value examination focuses on studying past and present price action to predict the probability of Extendicare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Extendicare's price. Additionally, you may evaluate how the addition of Extendicare to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |